Vir Biotechnology VIR 深 沪
等待开盘 12-17 09:30:00 美东时间
6.48
-0.240
-3.57%
华盛通- 最 高6.70
- 今 开6.68
- 成交量 159.91万股
- 最 低 6.36
- 昨 收 6.72
- 总市值 9.01亿
- 52周最高 14.45
- 市盈率 静 --
- 换手率 1.15%
- 52周最低 4.155
- 委 比 -43.82%
- 总股本 1.39亿
- 历史最高 141.01
- 量 比 1.10
- 振 幅 5.06%
- 历史最低 4.155
- 每 手 1
- 风险率 1.73%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Vir Biotechnology Secures Licensing Deal with Norgine
Vir Biotechnology ( ($VIR) ) just unveiled an update. On December 16, 2025, Vir...
今天 05:50
Vir Biotechnology Licenses Hepatitis Delta Therapy To Norgine In Up To €550 Million Deal, Secures €55 Million Upfront, And Up To €495 Million In Clinical, Regulatory And Sales Milestones, Along With Tiered, Mid-Teen To High-Twenties Percent Royalties On Net Sales
– Vir Biotechnology to receive EUR 55 million initial reimbursement payment upon closing, and up to EUR 495 million in clinical, regulatory and sales milestones, along with tiered, mid-teen to high-twenties percent
今天 05:07
Earnings Scheduled For November 5, 2025
Companies Reporting Before The Bell • Avient (NYSE:AVNT) is estimated to report...
11-05 19:12
Vir Biotechnology Completes Enrollment In ECLIPSE 1 Phase 3 Trial For Chronic Hepatitis Delta
– ECLIPSE 1 estimated date of last participant reaching primary endpoint (primary completion) in the fourth quarter of 2026, and topline data expected in the first quarter of 2027– ECLIPSE registrational program on
11-03 21:07
Medivir Postpones Nomination Committee Appointment Amid Rights Issue
Medivir AB ( ($SE:MVIR) ) has provided an announcement. Medivir AB has announce...
10-29 17:33
Theriva Biologics Addresses Unusual NYSE Trading Activity; Confirms No New Developments Since VIRAGE Trial Data Presentation At ESMO 2025
Theriva™ Biologics (NYSE:TOVX), ("Theriva" or the "Company"), a diversified clinical-stage company developing therapeutics designed to treat cancer and related diseases in areas of high unmet need, announced today
10-25 02:35
生产经营｜广船国际自主研发双燃料客滚船命名交付
10月23日，由广船国际为全球领先的运输与物流企业MSC地中海航运集团旗下客渡轮运营商Grandi Navi Veloci（GNV）量身打造的一艘现代化大型绿色...
10-24 18:12
Medivir Licenses Remetinostat to Biossil for Global Development
Medivir AB ( ($SE:MVIR) ) just unveiled an update. Medivir AB has entered an ex...
10-23 15:03
LoanCare Enhances its Digital Retention Platform with New Features
Latest enhancements include Paid in Full Monitoring and RateTrak VIRGINIA BEACH, Va., Oct. 15, 2025 /PRNewswire/ -- LoanCare®, a leading national mortgage subservicer, today announced two ne...
10-15 21:30
